ZOTANSEZota Health Care LImited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 17 Dec, 2025 · 23:02 IST

Zota Health Care sets QIP price at Rs 1,535 per share, around 5 percent discount to floor

Qip At DiscountQip At PremiumFund Raising View source PDFExplain this filing

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.9%Reaction day
₹1645.00
prior close
₹1649.30
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-4.5% vs market
Pharmaceuticals peers, median of 152sector-0.4%-4.4% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 4.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.2
10m
-2.3
15m
-2.6
30m
-4.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.9-0.3-4.5-0.4-4.4
Next day
-5.2+0.9-6.1+0.6-5.7
2d
-5.8+2.3-8.1+1.0-6.8
3d
-4.9+2.4-7.2+1.1-6.0
4d
-5.5+1.8-7.3+1.0-6.5
5d
-5.8+1.3-7.1+0.6-6.4
1w
-7.1+0.4-7.5-0.2-6.8
15d
-12.2-1.1-11.1-0.3-12.0
1m
-21.5-3.3-18.2-2.6-18.9
2m
-17.0-0.5-16.5-2.4-14.6
3m
-29.4-8.2-21.2-8.9-20.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zota Health Care has closed its QIP issue, allotting 22.80 lakh equity shares to qualified institutional buyers at Rs 1,535 per share, a premium of Rs 1,525 over face value of Rs 10. The price is at a discount of Rs 80.28 or 4.97 percent to the floor price of Rs 1,615.28, within SEBI allowed limits. Total issue size is approximately Rs 350 crore, which will strengthen the company's capital base for future growth.

Likely market impact

Equity dilution of about 2.28 million shares. Short-term price pressure possible; long-term impact depends on deployment of funds raised.